melanogenesis comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Updated 2026-05-08. Numbers and descriptions here follow the published literature rather than marketing material.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
Two structural changes distinguish the synthetic peptide from the natural hormone. A norleucine residue replaces methionine at one position, and a D-configured phenylalanine replaces the natural L-form at another. Both substitutions slow enzymatic breakdown, which extends the molecule's persistence relative to the parent hormone. The lactam bridge further constrains the backbone into a stable conformation. These features are standard design strategies in peptide chemistry and are not unique to this compound; they appear across many research peptides built for improved stability.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.
No regulatory authority has approved melanotan-2 for human use, and several countries classify it as a prescription-only or controlled substance, which restricts lawful supply. Material sold online is generally labelled as a research chemical and is not required to meet pharmaceutical standards of identity or purity. Published human data consist mainly of small uncontrolled studies, case reports and adverse-event notifications, so the evidence base is descriptive rather than confirmatory. Whether repeated melanocyte stimulation alters long-term naevus behaviour remains an open question that no completed trial has resolved.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic cyclic heptapeptide | Analog of alpha-MSH with an internal lactam bridge |
| Molecular weight | Approximately 1024 daltons | Free base value; salt forms differ |
| Appearance | White to off-white powder | Usually supplied as a lyophilized solid |
| Solubility | Freely soluble in water | Poorly soluble in nonpolar solvents |
| Typical storage | −20 °C, dry, protected from light | Repeated freeze-thaw cycles degrade peptides |
Published human data come mostly from small, short studies rather than large controlled trials. Reported outcomes include increased skin pigmentation and, in some reports, effects on appetite and libido, but sample sizes are small and follow-up is limited. Whether long-term use produces durable pigment changes or adverse effects is not established. Because products sold outside pharmacies are not standardized, the actual content of any given vial is often unknown. Independent testing of such material is uncommon.
Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.
Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.
Early published reports described melanotan-2 as a tanning agent without sun protection, which means darkening is not the same as protection against ultraviolet radiation. Later studies explored the peptide in erectile dysfunction, hemorrhagic shock, and some skin conditions. No regulator in the United States or Europe has approved it for clinical use. Many products labelled melanotan-2 are sold without approval and their identity and purity are unverified. Its long-term safety in humans remains an open question.
Melanotan-2, also written Melanotan II, is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone. Its sequence is Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2, and the lactam bridge between the aspartate and lysine side chains constrains the peptide into a ring. This structural change increases receptor affinity and metabolic stability relative to the native hormone. The compound was created in the 1980s as a research tool for studying pigmentation biology.
Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.
Melanotan II is a synthetic cyclic heptapeptide that acts as an agonist at melanocortin receptors. It was designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous peptide involved in pigment production. The analogue carries a lactam bridge that constrains the ring and slows enzymatic breakdown relative to the native hormone. In research literature it appears under several abbreviations, and naming conventions are not fully standardized. Published descriptions usually place it within the broader melanocortin agonist family.
Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.
==== Muscle testing ==== The main candidates for testing are those with a close relative who has had an episode of MH or have been shown to be susceptible. The standard procedure is the "caffeine-halothane contracture test", CHCT. A muscle biopsy is carried out at an approved research center, under local anesthesia. The fresh biopsy is bathed in solutions containing caffeine or halothane and observed for contraction; under good conditions, the sensitivity is 97% and the specificity 78%. Negative biopsies are not definitive, so any patient who is suspected of MH by their medical history or that of blood relatives is generally treated with non-triggering anesthetics, even if the biopsy was negative. Some researchers advocate the use of the "calcium-induced calcium release" test in addition to the CHCT to make the test more specific. Less invasive diagnostic techniques have been proposed. Intramuscular injection of halothane 6 vol% has been shown to result in higher than normal increases in local pCO2 among patients with known malignant hyperthermia susceptibility. The sensitivity was 100% and specificity was 75%. For patients at similar risk to those in this study, this leads to a positive predictive value of 80% and negative predictive value of 100%. This method may provide a suitable alternative to more invasive techniques. A 2002 study examined another possible metabolic test. In this test, intramuscular injection of caffeine was followed by local measurement of the pCO2; those with known MH susceptibility had a significantly higher pCO2 (63 versus 44 mmHg).
=== Distribution === From 1977 to 1981, SOLAR was distributed by RCA Records, which had also distributed the Soul Train Records label during its two-year run. Griffey formed a second label, Constellation Records (no relation to the Chicago-based indie label founded by Ewart Abner) in 1981, which focused on more contemporary and top forty-geared acts to Griffey's more traditionally "urban" establishment (including Jon Gibson and Klymaxx). Upon its formation, Constellation was distributed through Elektra/Asylum Records, making it only natural for the main SOLAR label to jump ship to Elektra for distribution when it left RCA. In the meantime, the Constellation label moved to MCA Records for distribution in 1984. Shortly thereafter, Griffey decided to abandon contemporary music to focus all of his attention on running SOLAR, and retaining its sonic theme. Subsequently, MCA bought the Constellation imprint and absorbed its artists, including Klymaxx, which had been its biggest act. SOLAR's relationship with Elektra lasted until 1986. After the Elektra distribution deal expired, SOLAR briefly took up distribution with Capitol Records until 1989, at which time it signed a new distribution deal with Epic Records, which oversaw what would ultimately become its twilight years. In the early 1990s, the label released its last recordings- 1991's Now by Richie Havens and Times 3's eponymous debut album, the soundtrack to the 1992 film Deep Cover, 3rd Avenue's 1992 debut album Let's Talk About Love, and 1993 The Deele album An Invitation To Love.
Maximum temperatures rather than minimum temperatures influence the weight of hatchlings unless the minimum temperature exceeds the tolerance limit. In later hatchlings warmer weather and decreased food availability promotes more rapid development resulting in a smaller body size compared to earlier hatchlings. The heaviest hatchlings come from colder habitats. Increased population density also results in decreased adult size as well as slower development.
Antigen processing Apoptosis Biogenesis of organelles Cell cycle and division DNA transcription and repair Differentiation and development Immune response and inflammation Neural and muscular degeneration Maintenance of pluripotency Morphogenesis of neural networks Modulation of cell surface receptors, ion channels and the secretory pathway Response to stress and extracellular modulators Ribosome biogenesis Viral infection Phage defense
Sources: en.wikipedia.org
== Carbon dioxide emissions == The BP Statistical Review of World Energy 2019 ranked Thailand the second highest CO2 emitter in ASEAN in 2018, estimating its emissions at 302 million tonnes. The other five largest ASEAN economies generated: Indonesia, 543 Mt; Malaysia, 250 Mt; Singapore, 230 Mt; Vietnam, 225 Mt; and Philippines, 134 Mt. In 1965, Thailand's CO2 emissions were 7.4 Mt. Global Carbon Project: In the Global Carbon Atlas 2014, of 216 nation states/territories, Thailand ranked 18 (1=most emissions, 216=fewest emissions) in CO2 emissions, up from 19 in 2013.
II. Full-thickness defects Full-thickness nasal defects are in three types: (i) wounds to the skin and to the soft tissues, featuring either exposed bone or exposed cartilage, or both; (ii) wounds extending through the nasal skeleton; and (iii) wounds traversing all three nasal layers: skin, muscle, and the osseo-cartilaginous framework. Based upon the dimensions (length, width, depth) and topographic locale of the wound and the number of missing nasal-tissue layers, the surgeon determines the rhinoplastic technique for correcting a full-thickness defect; each of the aesthetic nasal subunits is considered separately and in combination.
=== NAD-I Riboswitch === The NAD-I riboswitch (also called the nadA motif) was identified in species of the bacterial phylum Acidobacteriota, where it typically resides upstream of nadA genes encoding quinolate synthase, an enzyme in the de novo NAD⁺ biosynthesis pathway. Unusually, despite regulating genes relevant to NAD⁺ metabolism, neither binding domain of the NAD⁺-I riboswitch's dual-aptamer architecture has been shown to specifically recognize the nicotinamide portion of the coenzyme; instead, the RNA robustly binds the adenosine 5′-diphosphate (ADP) moiety of NAD⁺.
The proclamation of the March Constitution was followed by a short and turbulent period of constitutional order and parliamentary democracy that lasted until 1926. The legislature remained fragmented, without stable majorities, and governments changed frequently. The open-minded Gabriel Narutowicz was elected president according to the Constitution by the National Assembly in 1922, without popular vote. However, members of the nationalist right-wing faction did not regard his elevation as legitimate. They viewed Narutowicz rather as a traitor whose election was pushed through by the votes of alien minorities. Narutowicz and his supporters were subjected to an intense harassment campaign, and the president was assassinated on 16 December 1922, after serving only five days in office. Land reform measures were passed in 1919 and 1925 under pressure from an impoverished peasantry. They were partially implemented, but resulted in the parcellation of only 20% of the great agricultural estates. Poland endured numerous economic calamities and disruptions in the early 1920s, including waves of workers' strikes such as the 1923 Kraków riot. The German–Polish customs war, initiated by Germany in 1925, was one of the most damaging external factors that put a strain on Poland's economy. On the other hand, there were also signs of progress and stabilization, for example a critical reform of finances carried out by the competent government of Władysław Grabski, which lasted almost two years.
[A]n overwhelming preponderance of power [...] will remain wholly unattainable unless the Allies win the present war and the United States assumes responsibilities commensurate with its power—in the war, in the peace after the war and in the maintenance and improvement of the new order after the peace. The necessary preponderance of power is unlikely to emerge from any international combination other than a permanent alliance of the United States, the British Commonwealth of Nations, and the French Republic, with the addition of such Latin American states and such European democracies as may care to join. Such a coalition, if stable and permanent, could put an end to the world balance of power and oblige outside powers to abandon the game of power politics. No other coalition presently in prospect would seem to offer any comparable hope. In 1941, Alfred Vagts wrote an article, titled "The United States and the Balance of Power," in which he recalled the words of Thomas Jefferson:
Sources: en.wikipedia.org
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.
Melanotan-1, also called afamelanotide, is a shorter linear analog with a different amino acid sequence and no lactam ring. It has been evaluated in formal clinical programs, while melanotan-2 has not. The two are distinct molecules and are not interchangeable.
No. Bremelanotide is a related but distinct cyclic peptide that reached approved status for one specific clinical indication. Melanotan-2 is a separate molecule with its own sequence and properties. Shared ancestry in the melanocortin family does not make them the same substance.
No regulatory agency has authorised melanotan-2 as a medicine for any indication. It circulates mainly as a research chemical or through unregulated channels. As a result, identity, purity and content are not independently guaranteed.